Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
961–980 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
CHWYChewy, Inc.$9.87B40.0×$12.6B+6.2%$222.8M$485.2M$523.4MFair valued
PRAXPraxis Precision Medicines, Inc.$9.84B—$0-100.0%-$303.27M$474.76M$1.09MFair valued
SIRISirius Xm Holdings Inc.$9.83B11.5×$8.56B-1.6%$805M$174M$9.46BUndervalued
SPXCSPX Technologies, Inc.$9.82B34.4×$2.27B+14.2%$244M$166.4M$614.7MOvervalued
RRCRange Resources Corp$9.81B11.6×$2.99B+27.3%$658.02M$247K$1.02BFair valued
FCFSFirstCash Holdings, Inc.$9.8B25.8×$1.67B+10.7%$330.38M$172.3M$2.63BFair valued
FLSFlowserve Corp$9.75B26.9×$4.73B+3.8%$346.25M$731.01M$2.32BOvervalued
DRSLeonardo DRS, Inc.$9.75B30.5×$3.65B+12.8%$278M$270M$267MFair valued
LKNCYLuckin Coffee Inc.$9.74B20.5×$7.03B+48.9%$513.88M$327.44M$1.04BFair valued
ESTCElastic N.V.$9.73B25.9×$1.74B+17.3%$367.77M$879.87M$595.78MFair valued
IONSIonis Pharmaceuticals Inc$9.72B—$943.71M+33.8%-$381.39M$350.07M$262.48MOvervalued
OGEOge Energy Corp.$9.72B20.6×$3.19B+9.4%$470.7M$200K$5.86BFair valued
KYMRKymera Therapeutics, Inc.$9.7B—$39.21M-16.7%-$311.35M$124.48M$78.56MOvervalued
EATBrinker International, Inc$9.7B21.3×$5.81B+7.9%$487M$110M$1.76BFair valued
MPMP Materials Corp.$9.69B—$224.44M+10.1%-$85.87M$429.08M$952.52MOvervalued
JANJanus Living, Inc.$9.69B—$603.99M+6.2%$6.35M$1.56B—Overvalued
OSKOshkosh Corp$9.68B17.9×$10.42B-2.9%$647M$250.3M$1.15BFair valued
MTCHMatch Group, Inc.$9.67B14.9×$3.49B+0.2%$613.46M$580.58M$3.55BUndervalued
LTHLife Time Group Holdings, Inc.$9.63B23.6×$3B+14.3%$373.67M$223.65M$4.28BOvervalued
WLKWestlake Corp$9.63B—$11.17B-8.0%-$1.51B$1.64B$5.88BUndervalued